clopidogrel and eye

clopidogrel has been researched along with eye in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	1 (33.33)	2.80

Authors

Authors	Studies
Baltatzis, S; Gialeraki, A; Merkouri, E; Politou, M; Travlou, A	1
Can, M; Fortmann, SD; Hanley, DF; Kim, MH; Lordkipanidze, M; Marciniak, TA; Rao, SV; Serebruany, VL; Tanguay, JF	1
Ito, Y; Kimata, M; Koseki, T; Sekido, K; Tanaka, J; Yamada, S	1

Reviews

1 review(s) available for clopidogrel and eye

Article	Year
Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation. Thrombosis and haemostasis, 2016, 05-02, Volume: 115, Issue:5 Topics: Animals; Aspirin; Clopidogrel; Diplopia; Drug Approval; Eye; Humans; Lactones; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Receptor, PAR-1; Receptors, Proteinase-Activated; Ticlopidine; United States; United States Food and Drug Administration	2016

Article

Year

Vorapaxar and diplopia: Possible off-target PAR-receptor mismodulation.

Thrombosis and haemostasis, 2016, 05-02, Volume: 115, Issue:5

Topics: Animals; Aspirin; Clopidogrel; Diplopia; Drug Approval; Eye; Humans; Lactones; Peripheral Arterial Disease; Platelet Aggregation Inhibitors; Pyridines; Randomized Controlled Trials as Topic; Receptor, PAR-1; Receptors, Proteinase-Activated; Ticlopidine; United States; United States Food and Drug Administration

2016

Other Studies

2 other study(ies) available for clopidogrel and eye

Article	Year
Central retinal vein occlusion secondary to clomiphene treatment in a male carrier of factor V Leiden. Genetic testing and molecular biomarkers, 2009, Volume: 13, Issue:2 Topics: Adult; Clomiphene; Clopidogrel; Eye; Factor V; Fluorescein Angiography; Heterozygote; Humans; Infertility, Male; Male; Mutation; Retinal Vein Occlusion; Ticlopidine; Treatment Outcome	2009
Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database. Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2023, Volume: 26 Topics: Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Eye; Hemorrhage; Humans; Japan; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Rivaroxaban; Warfarin	2023

Article

Year

Central retinal vein occlusion secondary to clomiphene treatment in a male carrier of factor V Leiden.

Genetic testing and molecular biomarkers, 2009, Volume: 13, Issue:2

Topics: Adult; Clomiphene; Clopidogrel; Eye; Factor V; Fluorescein Angiography; Heterozygote; Humans; Infertility, Male; Male; Mutation; Retinal Vein Occlusion; Ticlopidine; Treatment Outcome

2009

Occurrence of intraocular hemorrhages under monotherapy or combination therapy of antiplatelets and anticoagulants using the Japanese Adverse Drug Event Report database.

Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, 2023, Volume: 26

Topics: Adverse Drug Reaction Reporting Systems; Aged; Anticoagulants; Aspirin; Clopidogrel; Drug Therapy, Combination; Eye; Hemorrhage; Humans; Japan; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Rivaroxaban; Warfarin

2023